- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Ajanta Pharma Limited — Board Meeting, 03-11-2025: Outcome of Board Meeting
03-11-2025 | 01:21 pm
03-11-2025 | 01:21 pm
Ajanta Pharma's board approved the financial results for the quarter and half-year. Consolidated PAT jumped 20% to ₹260 Cr, with revenue up 14% to ₹1,354 Cr for Q2. The company also declared an interim dividend of ₹28 per share (totaling ₹350 Cr).
No comments yet. Be the first to comment!